Journal of Global Antimicrobial Resistance

Papers
(The H4-Index of Journal of Global Antimicrobial Resistance is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Environmental antimicrobial resistance and its drivers: a potential threat to public health229
A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae137
Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years99
Challenges in the management of chronic wound infections81
Antibiotic resistance surveillance systems: A review81
Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacte76
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies69
Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection64
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”62
Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics58
Bedaquiline: Current status and future perspectives57
Italian young doctors’ knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional survey55
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter ba47
Carbapenemase-producing Gram-negative bacteria in aquatic environments: a review45
Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball44
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii44
Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: a systematic review43
Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus37
Staphylococcus aureus clones causing osteomyelitis: a literature review (2000–2020)36
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility34
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic33
Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence32
Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience32
Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)30
Advances in Fusarium drug resistance research30
Global genotype distribution of human clinical isolates of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae; A systematic review30
Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–201730
Epidemiology of mobile colistin resistance (mcr) genes in aquatic environments30
Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis29
0.039408922195435